GLP-1 boom in China, India, Brazil could create $22 billion market by 2035, J.P. Morgan saysThe China-India-Brazil market for GLP-1 weight-loss drugs could expand to $22 billion by 2035 from $6.6 billion currently, J.P. Morgan esti...
23 Oct, 2026, 03.50 PM IST
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruptionDr Reddy’s Laboratories has expanded its generic semaglutide portfolio with Obeda Pro and Obeda Plus after supplies of its original Obeda i...
23 Oct, 2026, 03.19 PM IST
Heineken document reveals worries over weight-loss drugs and beer salesHeineken has warned UK pubs about the increasing impact of weight-loss drugs on beer sales. These medications may reduce consumers' desire ...
23 Oct, 2026, 11.53 AM IST
Ozempic wave boosts US cobblers and tailors as Americans tighten their beltsConsumers in the US are experiencing significant changes in their wardrobes due to weight-loss medications. Many individuals are opting for...
22 Oct, 2026, 11.52 AM IST
Beauty firms chase 'Ozempic face' market as weight-loss drugs boomGalderma, Natura, and L'Oreal are developing treatments for consumers experiencing facial sagging due to rapid weight loss. These companies...
21 Oct, 2026, 11.33 AM IST
As weight-loss drug users turn to dietary supplements, doctors, regulators raise flagsThe growing use of GLP-1 weight-loss drugs such as Ozempic and Wegovy is driving demand for dietary supplements in the US, as users seek to...
20 Oct, 2026, 12.39 PM IST
Women tip the scale as weight-loss boom reaches tier-II citiesWhile startups such as General Catalyst-backed Voy and Mumbai-based Metago are seeing higher demand from women, Elevate Now, backed by Tita...
29 Sep, 2026, 06.00 AM IST
GLP-1 users are suing over vision loss: What does the evidence really show?Dozens of patients have taken legal action against drug manufacturers, filing personal injury lawsuits that allege they were not adequately...
24 Sep, 2026, 10.10 PM IST
European pharma chiefs warn region risks losing ground to America, ChinaDrugmakers for months have been warning they could curtail investments and delay the release of new medications in Europe, widening a dispa...
23 Sep, 2026, 12.49 AM IST
Ozempic maker Novo Nordisk sets sights on hair-loss marketThe condition is part of a list of areas, including addiction and menopause, where Novo sees potential overlap with either its core scienti...
23 Sep, 2026, 12.12 AM IST
Wegovy maker Novo Nordisk faces investor pressure to find growth beyond weight-loss drugsFacing increased scrutiny, Novo Nordisk must clarify its future strategy outside of its leading weight-loss drug. Investors are advocating ...
21 Sep, 2026, 11.36 AM IST
Did Ozempic manufacturer Novo Nordisk hide drug death reports? Here’s what FDA said about side-effect reportingDespite ongoing debate, medications such as Ozempic continue to rank among the most commonly prescribed treatments for weight management an...
17 Mar, 2026, 04.52 PM IST
Delhi HC allows Sun Pharma to manufacture, export its own weight loss drugThe Delhi High Court has allowed Sun Pharma to manufacture and export its version of semaglutide, the diabetes and anti-obesity drug made b...
10 Dec, 2025, 11.56 AM IST
Weight-loss drug Ozempic to debut in India soonNovo Nordisk will launch Ozempic in India. This injectable drug manages type 2 diabetes and aids weight loss. It enters a competitive marke...
26 Sep, 2025, 11.36 PM IST
Novo Nordisk's stock rises as Ozempic beat analysts' expectations in salesIn its outlook for 2025, Novo Nordisk has predicted 'continued periodic supply constraints and related drug shortage notifications'.
06 Feb, 2025, 01.38 AM IST
Ozempic: Bengaluru is the secret ingredient behind the wonder weight loss drugs' successNovo Nordisk's India team played a pivotal role in the success of Ozempic, a semaglutide-based drug for diabetes and weight management. The...
08 Jun, 2024, 11.59 AM IST
Novo Nordisk, maker of Ozempic and Wegovy sues two pharmacies for ‘selling impure drugs’Over alleged selling of contaminated drugs, two Florida-based pharmacies have been sued by Novo Nordisk. The company claims that the substa...
30 Nov, 2023, 11.41 PM IST